I-κB kinase β is critical for B cell proliferation and antibody response

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 577-587

  Ren, H ^a   Schmalstieg, A ^a   Yuan, D ^a   Gaynor, R B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD40 ANTIGEN; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN SUBCLASS; LIPOPOLYSACCHARIDE; MUTANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0037080025     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.577     Document Type: Article

References (74)

1. The NF-κB and IκB proteins: New discoveries and insights
2. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
3. Structure, regulation and function of NF-κB
4. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
5. Identification and characterization of an IκB kinase
6. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
7. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK
8. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
9. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
10. Phosphorylation meets ubiquitination: The control of NF-κB activity
11. Complementation cloning of NEMO, a component of the IKK complex essential for NF-κB activation
12. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex
13. IKKγ is an essential regulatory subunit of the IκB kinase complex
14. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis
15. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
16. Severe liver degeneration in mice lacking the IκB kinase 2 gene
17. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis
18. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKKβ-deficient mice
19. IKKI-deficient mice exhibit abnormal development of skin and skeleton
20. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
21. Limb and skin abnormalities in mice lacking IKKα
22. IKKα controls formation of the epidermis independently of NF-κB
23. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice
24. NEMO/IKKγ-deficient mice model incontinentia pigmenti
25. Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
26. Activators and target genes of Rel/NF-κB transcription factors
27. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
28. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
29. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
30. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
31. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
32. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
33. NF-κB RelA-deficient lymphocytes: Normal development oft cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses
34. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
35. Requirement for NF-κB in osteoclast and B-cell development
36. Multifocal defects in immune responses in RelB-deficient mice
37. (-/-) double-knockout mice
38. The combined absence of the transcription factors Rel and RelA leads to multiple hematopoietic cell defects
39. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells
40. Complex pattern of immunoglobulin μ gene expression in normal and transgenic mice: Nonoverlapping regulatory sequences govern distinct tissue specificities
41. Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors
42. B-cell development in the mouse
43. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells
44. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line
45. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB
46. Regulation of IgH chain gene transcription by IL-5
47. Effect of upstream RNA processing on selection of uS versus uM poly(A) sites
48. The role of NK cells during in vivo antigen-specific antibody responses
49. Role of the OCTA site in regulation of IgH chain gene transcription during B cell activation
50. HTLV-I Tax protein binds to MEKKI to stimulate IκB kinase activity and NF-κB activation
51. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
52. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
53. The role of the κ enhancer and its binding factor NF-κB in the developmental regulation of κ gene transcription
54. Inducible nuclear expression of NF-κB in primary B cells stimulated through the surface Ig receptor
55. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway
56. Nuclear factor κB is required for the development of marginal zone B lymphocytes
57. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
58. B lymphocytes differentially use the Rel and nuclear factor κBI (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
59. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
60. Regulation of IgM and IgD synthesis in B lymphocytes. I. Changes in biosynthesis of mRNA for μ- and δ-chains
61. IKKγ/NEMO facilitates the recruitment of the IκB proteins into the IκB kinase complex
62. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression
63. IκB kinase α is essential for mature B-cell development and function
64. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin DI
65. Genetic anaiysis of B cell antigen receptor signaling
66. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells
67. The molecular mechanism of B-cell activation by Toll-like receptor protein RP105
68. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
69. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-κB activation in primary B cells
70. T cell-independent antigens type 2
71. Regulation of the T-independent humoral response by Taci
72. Rapid restoration of B-cell function in XID mice by intravenous transfer of peritoneal cavity B cells
73. Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors
74. IKKβ is essential for protecting T cells from TNFα-induced apoptosis